Cargando…
Studies on Preformulation and Formulation of JIN-001 Liquisolid Tablet with Enhanced Solubility
This study aimed to develop a heat shock protein 90 (Hsp90) inhibitor liquisolid tablet with improved solubility to overcome low bioavailability issues. As an active pharmaceutical ingredient (API), JIN-001, a novel Hsp90 inhibitor, was reported to have substantial in vitro antiproliferative and in...
Autores principales: | Kim, Han-Sol, Kim, Chang-Min, Jo, An-Na, Kim, Joo-Eun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030333/ https://www.ncbi.nlm.nih.gov/pubmed/35455409 http://dx.doi.org/10.3390/ph15040412 |
Ejemplares similares
-
Formulation and in vitro evaluation of self-nanoemulsifying liquisolid tablets of furosemide
por: Dalal, Lena, et al.
Publicado: (2021) -
Liquisolid Tablets for Dissolution Enhancement of a Hypolipidemic Drug
por: Patel, D. S., et al.
Publicado: (2015) -
Preparation and Evaluation of Directly Compressible Orally Disintegrating Tablets of Cannabidiol Formulated Using Liquisolid Technique
por: Limpongsa, Ekapol, et al.
Publicado: (2022) -
Pharmacotechnical and analytical preformulation studies for cannabidiol orodispersible tablets
por: Vlad, Robert-Alexandru, et al.
Publicado: (2021) -
Formulation and Evaluation of Liquisolid Compacts for Olmesartan Medoxomil
por: Prajapati, Shailesh T., et al.
Publicado: (2013)